# Xenon Pharmaceuticals Inc.: Form 8-K, filed Oct 16, 2025

- Company: [Xenon Pharmaceuticals Inc.](/companies/xene.md) (CIK 1582313)
- Form: 8-K
- Filed: 2025-10-16
- Accepted by EDGAR: Oct 16, 2025, 21:16 ET
- Period: 2025-10-15
- Accession: 0001193125-25-241546
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1582313/000119312525241546/xene-20251015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1582313/000119312525241546/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1582313/000119312525241546/xene-20251015.htm

Filed Oct 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-241546. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.